Canada · Delayed Price · Currency is CAD Vantex Resources Statistics
Total Valuation
TSXV:VAX has a market cap or net worth of CAD 1.35 million. The enterprise value is 1.01 million.
| Market Cap | 1.35M |
| Enterprise Value | 1.01M |
Important Dates
The next estimated earnings date is Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:VAX has 4.81 million shares outstanding.
| Current Share Class | 4.81M |
| Shares Outstanding | 4.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.78 |
| P/TBV Ratio | 6.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.94 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.66 |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.25 |
| Quick Ratio | 2.19 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.08 |
| Interest Coverage | -35.46 |
Financial Efficiency
Return on equity (ROE) is -68.19% and return on invested capital (ROIC) is -47.20%.
| Return on Equity (ROE) | -68.19% |
| Return on Assets (ROA) | -34.75% |
| Return on Invested Capital (ROIC) | -47.20% |
| Return on Capital Employed (ROCE) | -119.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TSXV:VAX has paid 639 in taxes.
| Income Tax | 639 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +366.67% in the last 52 weeks. The beta is -0.07, so TSXV:VAX's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | +366.67% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 79.95 |
| Average Volume (20 Days) | 16,346 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -236,615 |
| Pretax Income | -204,868 |
| Net Income | -205,507 |
| EBITDA | -215,415 |
| EBIT | -236,615 |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 344,025 in cash and 12,108 in debt, with a net cash position of 331,917 or 0.07 per share.
| Cash & Cash Equivalents | 344,025 |
| Total Debt | 12,108 |
| Net Cash | 331,917 |
| Net Cash Per Share | 0.07 |
| Equity (Book Value) | 198,619 |
| Book Value Per Share | 0.04 |
| Working Capital | 198,619 |
Cash Flow
In the last 12 months, operating cash flow was -77,402 and capital expenditures -75,000, giving a free cash flow of -152,402.
| Operating Cash Flow | -77,402 |
| Capital Expenditures | -75,000 |
| Free Cash Flow | -152,402 |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:VAX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -15.26% |
| FCF Yield | -11.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 18, 2018. It was a reverse split with a ratio of 0.2.
| Last Split Date | May 18, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |